Transforming Vascular Access
Access Vascular was founded to address the most common and costly complications of intravenous therapy: infection, thrombosis, and phlebitis. Taking a foundationally different approach to thrombus reduction, the company manufactures intravenous catheters from a hydrophilic material which retains significant amounts of water. Engineered to mimic the body’s natural chemistry, Access Vascular catheters are designed to evade the foreign body response and complications that come with it. Our cleared products are HydroPICC®and HydroMID®.
Video- message from the CEO/Founder
-
Access Vascular Inc. Named 2022 MedTech Breakthrough Award Winner
Access vascular Receives FDA Clearance for HydroPICC Biomaterial- Based Dual-Lumen Catheter
Access Vascular, Inc. Opens New Facility Outside Boston With Expanded Production Capacity to Meet Growing Demand for Its Biomaterial Devices
Access Vascular, Inc. Secures $20 Million in Series B Financing